迈瑞医疗
(300760)
| 流通市值：1953.04亿 | | | 总市值：1954.88亿 |
| 流通股本：12.11亿 | | | 总股本：12.12亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 17,746,969,604 | 8,352,015,912 | 33,282,159,404 | 25,833,906,543 |
| 营业总成本 | 12,313,659,385 | 5,905,265,678 | 23,608,910,747 | 17,055,866,071 |
| 其他经营收益 | | | | |
| 营业利润 | 5,566,262,170 | 2,524,411,338 | 9,794,893,991 | 8,947,412,013 |
| 利润总额 | 5,556,093,706 | 2,541,347,680 | 9,673,965,739 | 8,901,611,832 |
| 净利润 | 5,046,906,080 | 2,426,538,126 | 8,451,471,405 | 7,813,893,576 |
| 每股收益 | | | | |
| 其他综合收益 | -363,071,595 | -243,472,238 | 278,427,564 | 399,264,979 |
| 综合收益总额 | 4,683,834,485 | 2,183,065,888 | 8,729,898,969 | 8,213,158,555 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 29,337,029,265 | 28,054,325,573 | 27,410,151,729 | 27,582,231,309 |
| 非流动资产: | | | | |
| 非流动资产合计 | 31,449,619,900 | 31,560,429,697 | 31,856,615,978 | 31,682,892,653 |
| 资产总计 | 60,786,649,165 | 59,614,755,270 | 59,266,767,707 | 59,265,123,962 |
| 流动负债: | | | | |
| 流动负债合计 | 12,445,389,725 | 11,745,169,549 | 11,599,605,662 | 10,837,818,630 |
| 非流动负债: | | | | |
| 非流动负债合计 | 3,038,531,371 | 3,024,022,455 | 4,655,841,992 | 4,182,499,045 |
| 负债合计 | 15,483,921,096 | 14,769,192,004 | 16,255,447,654 | 15,020,317,675 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 40,556,240,209 | 40,110,091,891 | 38,093,330,471 | 39,297,608,942 |
| 股东权益合计 | 45,302,728,069 | 44,845,563,266 | 43,011,320,053 | 44,244,806,287 |
| 负债和股东权益合计 | 60,786,649,165 | 59,614,755,270 | 59,266,767,707 | 59,265,123,962 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 20,008,785,131 | 9,571,514,876 | 38,829,326,170 | 29,101,013,212 |
| 经营活动现金流出小计 | 15,131,798,422 | 8,190,479,397 | 28,684,357,635 | 21,828,152,917 |
| 经营活动产生的现金流量净额 | 4,876,986,709 | 1,381,035,479 | 10,144,968,535 | 7,272,860,295 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,409,486,945 | 519,050,948 | 4,285,136,243 | 3,497,028,935 |
| 投资活动现金流出小计 | 2,276,401,948 | 1,148,328,845 | 4,794,531,618 | 3,622,930,407 |
| 投资活动产生的现金流量净额 | -866,915,003 | -629,277,897 | -509,395,375 | -125,901,472 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 53,805,023 | 6,092,323 | 135,827,785 | 123,206,650 |
| 筹资活动现金流出小计 | 2,558,075,841 | 406,030,842 | 6,859,510,992 | 5,052,608,794 |
| 筹资活动产生的现金流量净额 | -2,504,270,818 | -399,938,519 | -6,723,683,207 | -4,929,402,144 |
| 汇率变动对现金及现金等价物的影响 | -485,408,430 | -240,110,500 | -194,711,493 | -55,826,078 |
| 现金及现金等价物净增加额 | 1,020,392,458 | 111,708,563 | 2,717,178,460 | 2,161,730,601 |
| 期末现金及现金等价物余额 | 18,645,296,725 | 17,736,612,830 | 17,624,904,267 | 17,069,456,408 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 1,020,392,458 | - | 2,717,178,460 | - |
最新报告期：2026-09-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 喻胜锋,李虹达,王在存,贺菊颖 | 6.77 | 7.87 | 8.97 | 2026-09-30 |
| 中泰证券 | 祝嘉琦,谢木青 | 6.74 | 7.86 | 8.88 | 2026-09-07 |
| 中银证券 | 刘恩阳 | 7.10 | 8.10 | 9.40 | 2026-09-04 |
| 方正证券 | 许睿 | 7.18 | 8.11 | 9.29 | 2026-09-04 |
| 国泰海通 | 余文心,赵峻峰 | 6.99 | 7.84 | 8.90 | 2026-09-03 |